TOWA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,820 JPY | +3.29% |
|
+24.17% | +93.83% |
| Mar. 25 | Towa Pharmaceutical Completes Payment for Director Stock Compensation | MT |
| Feb. 07 | Towa Corporation Provides Dividend Guidance for the Year Ending March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company returns high margins, thereby supporting business profitability.
- The company is in a robust financial situation considering its net cash and margin position.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With an expected P/E ratio at 58.84 and 40 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Semiconductor Equipment & Testing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +93.83% | 2.15B | - | ||
| +34.73% | 176B | A- | ||
| +59.23% | 39.08B | C- | ||
| +39.55% | 34.77B | B+ | ||
| -11.01% | 29.86B | - | ||
| +18.35% | 21.39B | C | ||
| +2.13% | 11.32B | B+ | ||
| -14.45% | 11.22B | C- | ||
| +129.01% | 9.97B | - | ||
| +25.29% | 5.77B | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 6315 Stock
- Ratings TOWA Corporation
